Prevalence of poor medication adherence in type 2 diabetics in North Africa. Systematic review and meta-analysis.
##plugins.themes.academic_pro.article.main##
Abstract
Introduction: Medication adherence is the cornerstone of the successful drug management of a chronic disease. The objective of this study was to develop a systematic review and meta-analysis of the prevalence and the factors associated with non-adherence in patients with type 2 diabetes in North African countries.
Methods: A literature search was conducted on Medline via Pubmed with a complementary search on Google Scholar. The meta-analysis was conducted using the Metaprop function of R software. The Cochrane Q test and Higgins I² statistic were used to estimate the heterogeneity.
Results: In total, 16 studies measuring the prevalence of medication adherence in North African countries were selected in this systematic review. The combined prevalence of non-adherence was 38% (95% CI 30%-47%) with a random-effects model. The meta-analysis revealed a significant heterogeneity between studies (I² = 96%, p <0.01). Factors associated with non-adherence in type 2 diabetics were education level, social security coverage, therapeutic education, cost of medication, socioeconomic level, the duration of diabetes, unbalanced diabetic diet, polypharmacy, female gender, family support and age.
Conclusion: The combined prevalence of non-adherence among type 2 diabetics in North Africa was high and multifactorial, requiring global and integrated management by patients, physicians and pharmacists.
Keywords:
Medication Adherence - Diabetes Mellitus, Type 2 - Prevalence - Africa, Northern - Systematic review##plugins.themes.academic_pro.article.details##
References
- 1. Blackwell B. Drug therapy: patient compliance. N Engl J Med. 1973;289(5):249-52. 2. Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299-307. 3. Fédération internationale du diabète. L'Atlas du diabète de la FID. Bruxelles; 2019. 4. Institut National de Santé Publique. Programme INCO-MED. Étude TAHINA - La transition épidémiologique et son impact sur la santé dans les pays Nord africains. Alger; 2007. 5. Ministre de la santé, de la population et de la réforme hospitalière. Enquête nationale sur la mesure du poids des facteurs de risque des maladies non transmissibles selon l'approche STEPwise de l'OMS. Principaux résultats. Alger; 2017 6. Zaoui S, Biémont C, Meguenni K. Approche épidémiologique du diabète en milieux urbain et rural dans la région de Tlemcen (Ouest algérien). 2007;17(1):15-21. 7. Ouhaibi-Djellouli, H., Mediene-Benchekor, S., Lardjam-Hetraf, S. A., Hamani-Medjaoui, I., Meroufel, D. N., Boulenouar, H., Hermant, X., Saidi-Mehtar, N., Amouyel, P., Houti, L., Goumidi, L., & Meirhaeghe, A. (2014). The TCF7L2 rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population. BMC genetics, 15, 134. 8. Ben Romdhane H, Ben Ali S, Aissi W, Traissac P, Aounallah-Skhiri H, Bougatef S, Maire B, Delpeuch F, Achour N. Prevalence of diabetes in Northern African countries: the case of Tunisia. BMC Public Health. 2014;14:86. 9. Lamri L, Gripiotis E, Ferrario A. Diabetes in Algeria and challenges for health policy: a literature review of prevalence, cost, management and outcomes of diabetes and its complications. Global Health. 2014;10:11. 10. Ficher-Ghanassia, Ghanassia E, Bringer J. Le diabète, in: Endocrinologie - Nutrition 6ème édition. Paris; 2012. 11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353(5):487-97. 12. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006;333(7557):15 13. Yazew KG, Walle TA, Azagew AW. Prevalence of anti-diabetic medication adherence and determinant factors in Ethiopia: a systemic review and meta-analysis, 2019. Int J Afr Nurs Sci. 2019;11:100167. 14. Iglay K, Cartier SE, Rosen VM, Zarotsky V, Rajpathak SN, Radican L, Tunceli K. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Curr Med Res Opin. 2015;31(7):1283-96. 15. Gheorghiu B, Nayani S. Surveiller l'observance des médicaments : les conséquences pour les patients et les dispensateurs de soins. Healthc Manage Forum. 2018;31(3):112-115. 16. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43(6): 521-30. 17. Gedda M. Traduction française des lignes directrices PRISMA pour l'écriture et la lecture des revues systématiques et des méta-analyses. Kinesither Rev 2015; 15(157): 39-44 18. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 2009;6(7):e1000097. 19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP et al.The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration PLoS Med, 6 (7) (2009), p. e1000100 20. Badr W, Ghammam R, Ammar A, Ben Fredj S, Maatoug J, Ghannem H. L'observance thérapeutique chez le diabétique de type 2. Ann Endocrinol. 2018;79(4):476. 21. Ben Fatma NEH, Ben Abdallah I, Khochtali I. Évaluation de l'observance thérapeutique chez le diabétique hypertendu. Ann Endocrinol. 2018;79(4):476. 22. Ben Hamida S, Kolsi B, Ben Abdallah R, Hemriti H, Mnif F, Abid M. PCA-013: Observance thérapeutique chez les patients diabétiques types 2. Diabetes Metab. 2016;42:A100. 23. Chelbi S, Abdesslam H, Bendag N, Sallaouti M, Naceur KB, Oueslati I, et al. Diabétiques type 2 : observance thérapeutique et Ramadan. Ann Endocrinol. 2018;79(4):484. 24. Achouri MY, Mammeri M, Sehanine Y, Selka MA, Ghomari WI, Lahmer A, et al. Facteurs associés à la non-observance thérapeutique chez les diabétiques de type 2 : première enquête algérienne. Ann Pharm Fr. 2019;77(6):506-15. 25. Zahouani A., Missat FZ. Evaluation de l'observance thérapeutique chez les diabétiques au niveau du service de médecine interne CHU Tlemcen [Thèse d'exercice pour l'Obtention du diplôme de docteur en Pharmacie]. Tlemcen : Université Abou Bakr Belkaid de Tlemcen ; 2016. 26. Shams ME, Barakat EA. Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. Saudi Pharm J. 2010;18(4):225-32. 27. Mostafa HM, Ismail MAE-R, Mohamed RA. Assessment of adherence of type 2 diabetic patients to oral antihyperglycemic agents atel-Mahsama family Practice Center, Ismailia Governorate, Egypt. Adv.Biores. 2016;7:7. 28. Nashat Hegazy N. Quality of care and medication adherence among patients with type (2) diabetes mellitus. Egypt Fam Med J. 2017;1(2):1-13. 29. Heissam K, Abuamer Z, El-Dahshan N. Patterns and obstacles to oral antidiabetic medications adherence among type 2 diabetics in Ismailia, Egypt: a cross section study. Pan Afr Med J. 2015;20:177. 30. Tawfik El Adl, Ashraf Talaat, Osman Elsayed, Mohammed Shahda and Mostafa Neamatallah. Psychiatric morbidity and glycemic control in type 2 non obese diabetic egyptian Patients. Life Sci J. 2013;10(1): 1071-78. 31. Abainou L, Elhadri S, Chahbi Z, Kaddouri S, Qacif H, Zyani M, et al. Observance thérapeutique chez les patients suivis pour diabète type 2 : état des lieux et déterminants. J. Mar Endocrinol Diabétol. 2018;4:290-97. 32. Doubi S, El Ouahabi H, Dakkar O, Ajdi F. L'évaluation d'un programme d'éducation thérapeutique chez le patient diabétique dans un Centre Hospitalier Universitaire marocain: résultats préliminaires d'une enquête pilote [Evaluation of a therapeutic education program in diabetic patients in a Moroccan university hospital: preliminary results of a pilot survey]. Pan Afr Med J. 2014;18:258. 33. Farouqi A, Harti MA, Nejjari C. Prise en charge du diabète au Maroc : résultats de l'International Diabetes Management Practices Study (IDMPS) - Vague 2. Med Mal Metab. 2010; 4 : 704-11 34. Lamiaa H, Chadli A, Nsame D, El Aziz S, El Ghomari H, Farouqi A. P74 Rôle de l'observance thérapeutique sur l'équilibre glycémique chez le diabétique de type 2 marocain. Diabetes Metab. 2012;38:A49. 35. Ashur ST, Shah SA, Bosseri S, Morisky DE, Shamsuddin K. Illness perceptions of libyans with T2DM and their influence on medication adherence: a study in a diabetes center in Tripoli. Libyan J Med. 201 5;10(1):29797. 36. Jannoo Z, Mamode Khan N. Medication Adherence and Diabetes Self-Care Activities Among Patients With Type 2 Diabetes Mellitus. Value Health Reg Issues. 2019;18:30-35. 37. Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence. 2013 Jun 17;7:525-30. 38. Guénette L, Moisan J, Breton MC, Sirois C, Grégoire JP. Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance. Diabetes Metab. 2013;39(3):250-7. 39. Simard P, Presse N, Roy L, Dorais M, White-Guay B, Räkel A, Perreault S. Persistence and adherence to oral antidiabetics: a population-based cohort study. Acta Diabetol. 2015;52(3):547-56. 40. Jaam M, Ibrahim MIM, Kheir N, Awaisu A. Factors associated with medication adherence among patients with diabetes in the Middle East and North Africa region: A systematic mixed studies review. Diabetes Res Clin Pract. 2017;129:1-15. 41. Curkendall SM, Thomas N, Bell KF, Juneau PL, Weiss AJ. Predictors of medication adherence in patients with type 2 diabetes mellitus. Curr Med Res Opin. 2013;29(10):1275-86. 42. Tunceli K, Zhao C, Davies MJ, Brodovicz KG, Alexander CM, Iglay K, Radican L. Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes. Patient Prefer Adherence. 2015 Jan 28;9:191-7. 43. Koyanagi K, Kubota T, Kobayashi D, Kihara T, Yoshida T, Miisho T, Miura T, Sakamoto Y, Takaki J, Seo T, Shimazoe T. Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs. Front Pharmacol. 2016 Jul 20;7:212. doi: 10.3389/fphar.2016.00212. PMID: 27489544; PMCID: PMC4951482. 44. Khunti K, Seidu S, Kunutsor S, Davies M. Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis. Diabetes Care. 2017;40(11):1588-1596. 45. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005 Jul;27(7):1064-73. 46. Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, Aubert RE. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015;38(4):604-9. 47. Cramer JA, Benedict Ã, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review: Compliance in cardiovascular disease. Int J Clin Pract. 2007;62(1):76 87. 48. Tiv M, Viel J-F, Mauny F, Eschwège E, Weill A, Fournier C, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study. PloS One. 2012;7(3):e32412. 49. Bardoulat I, Chauvin F, De Saunière A, et al. L'observance médicamenteuse des patients diabétiques de type II en ÃŽle-de-France : état des lieux et priorités d'actions. In: 9e Colloque Données de santé en vie réelle, Paris, 13 juin 2017. Rev Épidémiol Santé Publique 2017;65(Suppl.3):S137. 50. Michiels Y, Bugnon O, Chicoye A, Dejager S, Moisan C, Allaert FA, Hunault C, Romengas L, Méchin H, Vergès B. Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study. Adv Ther. 2019;36(6):1291-1303. 51. Ettori-Ajasse I, Tatin E, Forbes G, Eldridge S, Dibao-Dina C. How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool. Trials. 2020;21(1):281. 52. I. Krass, P. Schieback, T. Dhippayom. Adherence to diabetes medication: a systematic review: Diabet. Med. 32, 725-737 (2015)